What does K Pharma,Inc. do?
K Pharma,Inc. engages in the research, development, manufacture, and sale of regenerative medicines and pharmaceutical products in Japan. It develops regenerative medicine products using disease-specific induced pluripotent stem (iPS) cell technology for spinal cord injuries and cerebral infarctions. The company was…
What is K Pharma,Inc.'s P/E and P/B ratio?
K Pharma,Inc. has a P/E ratio of -7.9 and a P/B ratio of 10.59.
What is K Pharma,Inc.'s debt-to-equity ratio?
K Pharma,Inc. has a debt-to-equity ratio of 2.12.
How much does K Pharma,Inc. owe compared with what it owns?
K Pharma,Inc. owes ¥0.70 for every ¥1 it owns (balance sheet Jun 2026), which is moderate.
What is K Pharma,Inc.'s Positivity rank?
K Pharma,Inc. is ranked #9,714 of 10,750 companies globally and #3,596 of 3,683 in Japan on PositoAI, with a Positivity Score of 14,755.
Does K Pharma,Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
Red flags (PosiRed) are not checked yet for companies in this market on PositoAI, so no result is shown for K Pharma,Inc..
Where can I read the latest news about K Pharma,Inc.?
Recent headlines about K Pharma,Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does K Pharma,Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of K Pharma,Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.